LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 122

Search options

  1. Article ; Online: Dose Selection in a Pandemic

    Kunyi Wu / Kimberly L. Bergman

    Clinical and Translational Science, Vol 14, Iss 1, Pp 5-

    A Framework Informed by the FDA Animal Rule

    2021  Volume 7

    Keywords Therapeutics. Pharmacology ; RM1-950 ; Public aspects of medicine ; RA1-1270
    Language English
    Publishing date 2021-01-01T00:00:00Z
    Publisher Wiley
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  2. Article: The microbial communities in

    Jiang, Bin / Wu, Li / Wang, Qi / Yang, Liran / Zheng, Jia / Zhou, Shulai / He, Cuirong / Jiao, Wenwen / Xu, Bin / Liu, Kunyi

    Food science & nutrition

    2022  Volume 10, Issue 8, Page(s) 2681–2693

    Abstract: Wuliangye- ... ...

    Abstract Wuliangye-flavor
    Language English
    Publishing date 2022-04-08
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2703010-6
    ISSN 2048-7177
    ISSN 2048-7177
    DOI 10.1002/fsn3.2872
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Dose Selection in a Pandemic: A Framework Informed by the FDA Animal Rule.

    Wu, Kunyi / Bergman, Kimberly L

    Clinical and translational science

    2020  Volume 14, Issue 1, Page(s) 5–7

    MeSH term(s) Animals ; Antiviral Agents/pharmacology ; Antiviral Agents/standards ; Antiviral Agents/therapeutic use ; COVID-19/drug therapy ; COVID-19/epidemiology ; COVID-19/virology ; Dose-Response Relationship, Drug ; Drug Dosage Calculations ; Drug Evaluation, Preclinical/standards ; Drug Evaluation, Preclinical/statistics & numerical data ; Humans ; Microbial Sensitivity Tests ; Pandemics/prevention & control ; Practice Guidelines as Topic ; SARS-CoV-2/drug effects ; Uncertainty ; United States/epidemiology ; United States Food and Drug Administration/standards
    Chemical Substances Antiviral Agents
    Keywords covid19
    Language English
    Publishing date 2020-12-16
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2433157-0
    ISSN 1752-8062 ; 1752-8054
    ISSN (online) 1752-8062
    ISSN 1752-8054
    DOI 10.1111/cts.12936
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Interaction and Metabolic Function of Microbiota during the Washed Processing of

    Shen, Xiaojing / Wang, Baijuan / Zi, Chengting / Huang, Lulu / Wang, Qi / Zhou, Chenchen / Wen, Wu / Liu, Kunyi / Yuan, Wenjuan / Li, Xingyu

    Molecules (Basel, Switzerland)

    2023  Volume 28, Issue 16

    Abstract: Coffee fermentation is crucial for flavor and aroma, as microorganisms degrade mucilage and produce metabolites. This study aimed to provide a basis for understanding the impact of microorganisms ... ...

    Abstract Coffee fermentation is crucial for flavor and aroma, as microorganisms degrade mucilage and produce metabolites. This study aimed to provide a basis for understanding the impact of microorganisms on
    MeSH term(s) Coffea ; Coffee ; China ; Fermentation ; Microbiota ; Saccharomycetales
    Chemical Substances Coffee
    Language English
    Publishing date 2023-08-16
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 1413402-0
    ISSN 1420-3049 ; 1431-5165 ; 1420-3049
    ISSN (online) 1420-3049
    ISSN 1431-5165 ; 1420-3049
    DOI 10.3390/molecules28166092
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Risk factors for portal hypertensive gastropathy.

    Wu, Ran / Liu, Kunyi / Shi, Chengyi / Tian, Hui / Wang, Na

    BMC gastroenterology

    2022  Volume 22, Issue 1, Page(s) 436

    Abstract: Background: Portal hypertensive gastropathy (PHG) is often underestimated in clinical diagnosis. Gastrointestinal bleeding in cirrhosis of PHG accounts for approximately 10% of upper gastrointestinal bleeding. However, the relationship between PHG and ... ...

    Abstract Background: Portal hypertensive gastropathy (PHG) is often underestimated in clinical diagnosis. Gastrointestinal bleeding in cirrhosis of PHG accounts for approximately 10% of upper gastrointestinal bleeding. However, the relationship between PHG and gender, laboratory parameters, liver function and varices is still controversial. In the present study, we aimed to retrospectively evaluate the incidence of PHG and to explore the relationship between PHG and gender, laboratory parameters, liver function and varicose veins.
    Methods: A retrospective analysis of 325 patients with cirrhosis who underwent esophagogastroduodenoscopy (EGD) in the Department of Gastroenterology of the Second Hospital of Hebei Medical University from 1 January 2018 to 31 December 2020 was performed. The relationships among age, gender, laboratory parameters, Child-Pugh stage, oesophageal varices (EV), gastric varices (GV) and ascites with PHG were analysed with univariate and multivariate logistic regression.
    Results: The occurrence of PHG was significantly associated with gender, haemoglobin, platelet count, prothrombin time, albumin, Child-Pugh stage, EV, GV and ascites (P < 0.05). Furthermore, there was a positive correlation between the severity of PHG and the degree of EV, GV and ascites (P < 0.05). Multivariate logistic regression showed that albumin, EV and GV levels were independently associated with the occurrence of PHG.
    Conclusion: The incidence of PHG in cirrhosis was 87.4% in this study. The occurrence of PHG was related to gender, haemoglobin, platelet count, prothrombin time, albumin, Child-Pugh stage, EV, GV and ascites. Albumin, the degree of EV and GV are independent risk factors for the occurrence of PHG.
    MeSH term(s) Albumins ; Ascites/complications ; Esophageal and Gastric Varices/complications ; Esophageal and Gastric Varices/etiology ; Gastrointestinal Hemorrhage/complications ; Gastrointestinal Hemorrhage/etiology ; Humans ; Hypertension, Portal/complications ; Liver Cirrhosis/epidemiology ; Retrospective Studies ; Risk Factors ; Stomach Diseases/complications ; Stomach Diseases/epidemiology
    Chemical Substances Albumins
    Language English
    Publishing date 2022-10-14
    Publishing country England
    Document type Journal Article
    ZDB-ID 2041351-8
    ISSN 1471-230X ; 1471-230X
    ISSN (online) 1471-230X
    ISSN 1471-230X
    DOI 10.1186/s12876-022-02468-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Antimicrobial Dose Selection under the Animal Rule.

    Wu, Kunyi / Choi, Su-Young / Bergman, Kimberly / Seo, Shirley

    Clinical pharmacology and therapeutics

    2021  Volume 109, Issue 4, Page(s) 971–976

    Abstract: The Food and Drug Administration's (FDA's) "Animal Rule" provides a unique regulatory pathway for drugs and biologics intended to treat serious or life-threatening conditions caused by exposure to lethal or permanently disabling chemical, biological, ... ...

    Abstract The Food and Drug Administration's (FDA's) "Animal Rule" provides a unique regulatory pathway for drugs and biologics intended to treat serious or life-threatening conditions caused by exposure to lethal or permanently disabling chemical, biological, radiological, or nuclear agents when human efficacy studies are not ethical and field trials are not feasible. Human dose selection under the Animal Rule is based on integrating the totality of clinical pharmacology evidence collected in in vitro, animal, and human studies. This review discusses the necessary pharmacokinetic and pharmacodynamic information and methods for determining the effective human dose of antimicrobials under the Animal Rule and presents case studies illustrating the utility of a totality of evidence approach for different methods.
    MeSH term(s) Animals ; Anti-Infective Agents/administration & dosage ; Anti-Infective Agents/pharmacokinetics ; Anti-Infective Agents/pharmacology ; Disease Models, Animal ; Dose-Response Relationship, Drug ; Drug Approval ; Drug Dosage Calculations ; Humans ; Research Design ; United States ; United States Food and Drug Administration/organization & administration ; United States Food and Drug Administration/standards
    Chemical Substances Anti-Infective Agents
    Language English
    Publishing date 2021-03-06
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 123793-7
    ISSN 1532-6535 ; 0009-9236
    ISSN (online) 1532-6535
    ISSN 0009-9236
    DOI 10.1002/cpt.2201
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Protective role of pyrroloquinoline quinone against gentamicin induced cochlear hair cell ototoxicity.

    Wu, Kunyi / Wang, Botao / Cao, Bo / Ma, Weijun / Zhang, Yan / Cheng, Ying / Hu, Juan / Gao, Ying

    Journal of applied toxicology : JAT

    2023  Volume 44, Issue 2, Page(s) 235–244

    Abstract: Gentamicin (GM) is one of the commonly used antibiotics in the aminoglycoside class but is ototoxic, which constantly impacts the quality of human life. Pyrroloquinoline quinone (PQQ) as a redox cofactor produced by bacteria was found in soil and foods ... ...

    Abstract Gentamicin (GM) is one of the commonly used antibiotics in the aminoglycoside class but is ototoxic, which constantly impacts the quality of human life. Pyrroloquinoline quinone (PQQ) as a redox cofactor produced by bacteria was found in soil and foods that exert an antioxidant and redox modulator. It is well documented that the PQQ can alleviate inflammatory responses and cytotoxicity. However, our understanding of PQQ in ototoxicity remains unclear. We reported that PQQ could protect against GM-induced ototoxicity in House Ear Institute-Organ of Corti 1 (HEI-OC1) cells in vitro. To evaluate reactive oxygen species (ROS) production and mitochondrial function, ROS and JC-1 staining, oxygen consumption rate (OCR), and extracellular acidification rate (ECAR) measurements in living cells, mitochondrial dynamics analysis was performed. GM-mediated damage was performed by reducing the production of ROS and inhibiting mitochondria biogenesis and dynamics. PQQ ameliorated the cellular oxidative stress and recovered mitochondrial membrane potential, facilitating the recovery of mitochondrial biogenesis and dynamics. Our in vitro findings improve our understanding of the GM-induced ototoxicity with therapeutic implications for PQQ.
    MeSH term(s) Humans ; Gentamicins/metabolism ; Reactive Oxygen Species/metabolism ; PQQ Cofactor/pharmacology ; PQQ Cofactor/therapeutic use ; PQQ Cofactor/metabolism ; Ototoxicity/etiology ; Ototoxicity/prevention & control ; Ototoxicity/metabolism ; Hair Cells, Auditory/metabolism ; Anti-Bacterial Agents/metabolism ; Apoptosis
    Chemical Substances Gentamicins ; Reactive Oxygen Species ; PQQ Cofactor (72909-34-3) ; Anti-Bacterial Agents
    Language English
    Publishing date 2023-08-31
    Publishing country England
    Document type Journal Article
    ZDB-ID 604625-3
    ISSN 1099-1263 ; 0260-437X
    ISSN (online) 1099-1263
    ISSN 0260-437X
    DOI 10.1002/jat.4535
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Chlorogenic Acid Attenuates Hepatic Steatosis by Suppressing ZFP30.

    Ding, Han / Ge, Kunyi / Fan, Changyu / Liu, Dandan / Wu, Chenyu / Li, Rongpeng / Yan, Feng-Juan

    Journal of agricultural and food chemistry

    2023  Volume 72, Issue 1, Page(s) 245–258

    Abstract: Nonalcoholic fatty liver disease (NAFLD) has become a major global health problem with no approved pharmacological treatment for this disease. Thus, it is urgent to develop effective therapeutic targets for clinical intervention. Here, we show for the ... ...

    Abstract Nonalcoholic fatty liver disease (NAFLD) has become a major global health problem with no approved pharmacological treatment for this disease. Thus, it is urgent to develop effective therapeutic targets for clinical intervention. Here, we show for the first time that ZFP30, a member of the KRAB-ZFP family, is significantly increased in NAFLD models. ZFP30 silencing ameliorates free fatty acid (FFA)-induced lipid accumulation; in contrast, the ZFP30 overexpression exacerbates the triglyceride accumulation and steatosis in hepatocytes. Further investigation revealed that the effects of ZFP30 on hepatic lipid accumulation were mainly attributed to the PPARα downregulation in the NAFLD model. Mechanistically, ZFP30 directly binded to the promoter of PPARα and recruited KAP1 to suppress its transcription. Moreover, chlorogenic acid (CGA) reversed the upregulation of ZFP30 in NAFLD, promoting the PPARα expression, resulting in enhanced fatty acid oxidation and alleviated hepatic steatosis. Collectively, our study indicates ZFP30 as a potential target for NAFLD treatment.
    MeSH term(s) Humans ; Animals ; Mice ; Non-alcoholic Fatty Liver Disease/drug therapy ; Non-alcoholic Fatty Liver Disease/genetics ; Non-alcoholic Fatty Liver Disease/metabolism ; Chlorogenic Acid/pharmacology ; Chlorogenic Acid/metabolism ; PPAR alpha/genetics ; PPAR alpha/metabolism ; Liver/metabolism ; Lipid Metabolism ; Fatty Acids, Nonesterified/metabolism ; Mice, Inbred C57BL ; Diet, High-Fat
    Chemical Substances Chlorogenic Acid (318ADP12RI) ; PPAR alpha ; Fatty Acids, Nonesterified
    Language English
    Publishing date 2023-12-26
    Publishing country United States
    Document type Journal Article
    ZDB-ID 241619-0
    ISSN 1520-5118 ; 0021-8561
    ISSN (online) 1520-5118
    ISSN 0021-8561
    DOI 10.1021/acs.jafc.3c02988
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Immunochromatographic Assay based on Sc-TCPP 3D MOF for the rapid detection of imidacloprid in food samples.

    Wang, Ying / Zhang, Meng / Bu, Tong / Bai, Feier / Zhao, Shuang / Cao, Yuanyuan / He, Kunyi / Wu, Haiyu / Xi, Jia / Wang, Li

    Food chemistry

    2022  Volume 401, Page(s) 134131

    Abstract: In this work, a highly sensitive immunochromatographic test strip (ITS) based on Scandium-Tetrakis (4-carboxyphenyl) porphyrin (TCPP) metal-organic framework nanocubes (ScTMNs) was developed for ultrasensitive and facile visual determination of ... ...

    Abstract In this work, a highly sensitive immunochromatographic test strip (ITS) based on Scandium-Tetrakis (4-carboxyphenyl) porphyrin (TCPP) metal-organic framework nanocubes (ScTMNs) was developed for ultrasensitive and facile visual determination of imidacloprid (IDP). TCPP as the porphyrin-based planar ligand and Sc
    MeSH term(s) Limit of Detection ; Food Contamination/analysis ; Metal-Organic Frameworks/analysis ; Ligands ; Scandium/analysis ; Inosine Diphosphate ; Porphyrins ; Chromatography, Affinity/methods ; Immunoassay ; Antibodies, Monoclonal
    Chemical Substances imidacloprid (3BN7M937V8) ; tetracarboxyphenylporphine (14609-54-2) ; Metal-Organic Frameworks ; Ligands ; Scandium (YUJ4U1EW7R) ; Inosine Diphosphate (86-04-4) ; Porphyrins ; Antibodies, Monoclonal
    Language English
    Publishing date 2022-09-08
    Publishing country England
    Document type Journal Article
    ZDB-ID 243123-3
    ISSN 1873-7072 ; 0308-8146
    ISSN (online) 1873-7072
    ISSN 0308-8146
    DOI 10.1016/j.foodchem.2022.134131
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Application of Population Pharmacokinetic Modeling, Exposure-Response Analysis, and Classification and Regression Tree Analysis to Support Dosage Regimen and Therapeutic Drug Monitoring of Plazomicin in Complicated Urinary Tract Infection Patients with Renal Impairment.

    Zhuang, Luning / Wu, Kunyi / Jang, Seong H / Reynolds, Kellie S / Mishra, Shrimant / Iarikov, Dmitri

    Antimicrobial agents and chemotherapy

    2022  Volume 66, Issue 4, Page(s) e0207421

    Abstract: In 2018, the FDA approved plazomicin for the treatment of complicated urinary tract infections (cUTI) including pyelonephritis in adult patients with limited or no alternative treatment options. The objective of this article is to provide the scientific ... ...

    Abstract In 2018, the FDA approved plazomicin for the treatment of complicated urinary tract infections (cUTI) including pyelonephritis in adult patients with limited or no alternative treatment options. The objective of this article is to provide the scientific rationales behind the recommended dosage regimen and therapeutic drug monitoring (TDM) of plazomicin in cUTI patients with renal impairment. A previous population pharmacokinetic (PK) model was used to evaluate the dosage regimen in cUTI patients with different degrees of renal impairment. The exposure-response analysis was conducted to identify the relationship between plazomicin exposure and nephrotoxicity incidence in cUTI patients with renal impairment. Classification and regression tree (CART) analysis was utilized to assess the TDM strategy. The receiver operating characteristics curve was plotted to compare two TDM thresholds in cUTI patients with renal impairment. The analyses suggested that dose reduction is necessary for cUTI patients with moderate or severe renal impairment. TDM should be implemented for cUTI patients with mild, moderate, or severe renal impairment to reduce the risk of nephrotoxicity. The trough concentration of 3 μg/mL is a reasonable TDM threshold to reduce the nephrotoxicity incidence while maintaining efficacy in cUTI patients with renal impairment. The application of population PK modeling, exposure-response analysis, and CART analysis allowed for the evaluation of a dosage regimen and TDM strategy for plazomicin in cUTI patients with renal impairment. Our study demonstrates the utility of pharmacometrics and statistical approaches to inform a dosage regimen and TDM strategy for drugs with narrow therapeutic windows.
    MeSH term(s) Adult ; Anti-Bacterial Agents/pharmacokinetics ; Drug Monitoring ; Female ; Humans ; Male ; Renal Insufficiency/chemically induced ; Renal Insufficiency/drug therapy ; Sisomicin/analogs & derivatives ; Sisomicin/pharmacokinetics ; Urinary Tract Infections/drug therapy
    Chemical Substances Anti-Bacterial Agents ; plazomicin (LYO9XZ250J) ; Sisomicin (X55XSL74YQ)
    Language English
    Publishing date 2022-03-08
    Publishing country United States
    Document type Journal Article
    ZDB-ID 217602-6
    ISSN 1098-6596 ; 0066-4804
    ISSN (online) 1098-6596
    ISSN 0066-4804
    DOI 10.1128/aac.02074-21
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top